393 related articles for article (PubMed ID: 36474108)
1. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases.
Wilcox JA; Boire AA
CNS Drugs; 2023 Jan; 37(1):45-67. PubMed ID: 36474108
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to treating leptomeningeal metastases.
Grewal J; Saria MG; Kesari S
J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal Metastases: New Opportunities in the Modern Era.
Wilcox JA; Li MJ; Boire AA
Neurotherapeutics; 2022 Oct; 19(6):1782-1798. PubMed ID: 35790709
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
5. New strategies for the treatment of breast cancer with leptomeningeal metastasis.
Chew SM; Seidman AD
Curr Opin Oncol; 2023 Nov; 35(6):500-506. PubMed ID: 37820086
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments.
Zheng MM; Tu HY; Yang JJ; Zhang XC; Zhou Q; Xu CR; Jiang BY; Yang XN; Yang XR; Deng JY; Yang MY; Xu BF; Chen XM; Li YS; Wu YL
Eur J Cancer; 2021 Jun; 150():23-30. PubMed ID: 33882375
[TBL] [Abstract][Full Text] [Related]
7. Management of leptomeningeal metastases in non-small cell lung cancer.
Patil S; Rathnum KK
Indian J Cancer; 2019 Nov; 56(Supplement):S1-S9. PubMed ID: 31793437
[TBL] [Abstract][Full Text] [Related]
8. Autocrine GMCSF Signaling Contributes to Growth of HER2
Ansari KI; Bhan A; Saotome M; Tyagi A; De Kumar B; Chen C; Takaku M; Jandial R
Cancer Res; 2021 Sep; 81(18):4723-4735. PubMed ID: 34247146
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of non-Hodgkin's lymphoma patients with leptomeningeal metastases.
Meng X; Yu J; Fan Q; Li L; Li W; Song Z; Liu X; Jiang Y; Gao M; Zhang H
Int J Clin Oncol; 2018 Aug; 23(4):783-789. PubMed ID: 29558001
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study.
Tamiya A; Tamiya M; Nishihara T; Shiroyama T; Nakao K; Tsuji T; Takeuchi N; Isa SI; Omachi N; Okamoto N; Suzuki H; Okishio K; Iwazaki A; Imai K; Hirashima T; Atagi S
Anticancer Res; 2017 Aug; 37(8):4177-4182. PubMed ID: 28739703
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
12. Treatment Options for Leptomeningeal Metastases of Solid Cancers: Literature Review and Personal Experience.
Kondoh T; Sonoda T
Acta Neurochir Suppl; 2021; 128():71-84. PubMed ID: 34191063
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
14. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
16. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
[TBL] [Abstract][Full Text] [Related]
17. Leptomeningeal disease.
Groves MD
Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
[TBL] [Abstract][Full Text] [Related]
18. Management of leptomeningeal carcinomatosis and challenges of trial design.
Gill CM; Brastianos PK
Curr Opin Oncol; 2019 Nov; 31(6):508-513. PubMed ID: 31503030
[TBL] [Abstract][Full Text] [Related]
19. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
[TBL] [Abstract][Full Text] [Related]
20. Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients.
Ha B; Chung SY; Kim YJ; Gwak HS; Chang JH; Lee SH; Park IH; Lee KS; Lee S; Kim TH; Kim DY; Kang SG; Suh CO
Cancer Res Treat; 2017 Jul; 49(3):748-758. PubMed ID: 27809457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
